vimarsana.com

SEC Tests Insider-Trading Theory at Trial of Ex-Biotech Executive

Card image cap

(Bloomberg) -- A lawyer for the US Securities and Exchange Commission told a jury that a former biotech executive’s $120,000 windfall on a trade in a competing company’s stock was “like betting on a game when you know who’s going to win” because he knew the pending takeover of his firm would likely boost its rival.Most Read from BloombergTrump’s Net Worth Hits $6.5 Billion, Making Him One of World’s 500 Richest PeopleBiden Gains Ground Against Trump in Six Key States, Poll ShowsTrump Vows to Pay

Related Keywords

San Francisco , California , United States , Gurbir Grewal , Matthew Meyerhofer , Austin Weinstein , Jack Dicanio , Alex Lee , Bloomberg Businessweek , Matthew Panuwat , Gary Gensler , Matthew Bultman , William Orrick , Incyte Corp , Northwestern Pritzker School Of Law , Exchange Commission , Bloomberg , Pfizer , Us District Court , Pfizer Inc , Mcdonald Corp , Medivation Inc , Chair Gary Gensler , Northwestern Pritzker School , Judge William Orrick , Northern District ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.